High prevalence of biochemical acromegaly in primary care patients with elevated IGF-1 levels.
about
AcromegalyThe risks of overlooking the diagnosis of secreting pituitary adenomasChallenges in the diagnosis and management of acromegaly: a focus on comorbidities.Implementing a screening program for acromegaly in Latin America: necessity versus feasibilityLanreotide extended-release aqueous-gel formulation, injected by patient, partner or healthcare provider in patients with acromegaly in the United States: 1-year data from the SODA registry.Metformin inhibits proliferation and growth hormone secretion of GH3 pituitary adenoma cells.Contextualized analysis of a needs assessment using the Theoretical Domains Framework: a case example in endocrinology.Triglycerides and stroke risk prediction: lessons from a prospective cohort study in german primary care patients.Surgical management of acromegaly in a resource-challenged environment.Gamma knife radiosurgery for acromegaly.Pharmacokinetic evaluation of lanreotide.Improvement of cardiac parameters in patients with acromegaly treated with medical therapies.Safety review: dose optimization of somatostatin analogs in patients with acromegaly and neuroendocrine tumors.The changing face of acromegaly--advances in diagnosis and treatment.Characteristics of acromegaly in Korea with a literature review.Emerging drugs for acromegaly.Epidemiology and etiopathogenesis of pituitary adenomas.Incidence and prevalence of clinically relevant pituitary adenomas: retrospective cohort study in a Health Management Organization in Buenos Aires, Argentina.Current management practices for acromegaly: an international survey.Acromegaly discovered during a routine out-patient surgical procedure: a case report.Prevalence of acromegaly in patients with symptoms of sleep apnea.Treatment of Acromegaly: Are We Satisfied With the Current Outcome?IGF1 as a Potential Treatment for Rett Syndrome: Safety Assessment in Six Rett PatientsSeeing the unseen: diagnosing acromegaly in a dental setup.Early diagnosis of acromegaly: computers vs clinicians.Automatic Detection of Acromegaly From Facial Photographs Using Machine Learning Methods.Laboratory investigation of acromegaly: is basal or random GH > 0.4 µg/L in the presence of normal serum IGF-1 an important result?Acromegaly with negative pituitary MRI and no evidence of ectopic source: the role of transphenoidal pituitary exploration?Screening for acromegaly in adult patients not reporting enlargement of the extremities, but with arterial hypertension associated with another comorbidity of the disease.Discordant growth hormone and IGF-1 levels post pituitary surgery in patients with acromegaly naïve to medical therapy and radiation: what to follow, GH or IGF-1 values?Long-term results of hypofractionated stereotactic radiotherapy with CyberKnife for growth hormone-secreting pituitary adenoma: evaluation by the Cortina consensus.Can elevated IGF-1 levels among patients with Ehlers-Danlos syndrome cause idiopathic intracranial hypertension?Acromegaly: a challenging condition to diagnose
P2860
Q21202912-F477EA1A-D646-4BFA-8A69-F85C041BD395Q28076665-9E1B38BD-7B79-4B1A-BF9C-2206C4B5163AQ30249746-8AADADAB-BE8E-4740-A5F4-42E1E263297AQ30251471-DEEEB947-320A-4496-B6A6-09DF19E7DB61Q30585813-B7358E71-ED3C-456E-B66A-CC71CA94A2E1Q33914014-94BB76D2-B938-46B9-A92A-4CA1A56FB62AQ34009361-AAF3C7E9-2C76-4C72-AE59-1656FA1AF573Q34435185-50715851-850D-451C-AC3E-68E589E5FEA5Q35041686-0E266BA0-0705-4896-A8EB-9AC418D5C8FEQ35810502-C0731A80-DF59-4756-A00C-44226216A7FAQ37780553-39DD18B4-4065-4978-B5FB-822500AC4F77Q37895525-43186936-BBC5-4D8B-B31E-35AE6153E5AEQ37941521-E6750386-5D9A-4B95-AA27-77C8254B126AQ38021680-35D15839-2F1A-463C-879E-F715D2988796Q38176366-2903F62A-141B-4E5E-AED4-F8D9D8AE792EQ38176659-DF23C17A-C4B5-4120-9264-8A48FE401A26Q38183762-CB665B90-DCFA-4679-BE66-B92B3A1831FFQ39095659-2CDB5318-C916-4436-8C8E-E08A65581732Q39818772-C78641B5-E8D9-431B-9D35-4F8F59B4B4A6Q41053598-8B2AE9E7-9279-4CFD-A3B2-077E83D3D564Q41229343-E5C2D9F0-F00E-483A-B989-AA545AE7987BQ41625092-9827A01F-3E38-43D5-9ACD-322EB60F6C8EQ42049161-25470797-4E11-49AB-90C0-C6CF22AD1D46Q42106376-2F06E210-9DBD-463C-B810-4B67EC767B5CQ45066617-ED7253A2-E7F1-4333-A0EA-BCD51B1862ECQ47173232-4024DEC4-1C26-4AA4-8696-E2A3EC040284Q48201657-31FADB67-416D-4A4A-BD38-E946266BC7CFQ48411293-9E649763-CDCF-49D0-90E2-4DA6F83761D2Q48427051-B313C23B-F459-4246-AD6D-804E9158BECEQ48766407-E408144E-0A65-400A-8156-A0226DECAFC9Q50249484-941E122A-D66D-4A5E-92A0-6A3340F55DA1Q54550732-92D06C3C-9E14-437D-ABC6-369C5BD18234Q58706936-A77120F3-128D-4BB6-BA94-FC184C0F14A4
P2860
High prevalence of biochemical acromegaly in primary care patients with elevated IGF-1 levels.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
High prevalence of biochemical ...... ts with elevated IGF-1 levels.
@en
High prevalence of biochemical ...... ts with elevated IGF-1 levels.
@nl
type
label
High prevalence of biochemical ...... ts with elevated IGF-1 levels.
@en
High prevalence of biochemical ...... ts with elevated IGF-1 levels.
@nl
prefLabel
High prevalence of biochemical ...... ts with elevated IGF-1 levels.
@en
High prevalence of biochemical ...... ts with elevated IGF-1 levels.
@nl
P2093
P1476
High prevalence of biochemical ...... ts with elevated IGF-1 levels.
@en
P2093
G K Stalla
H J Schneider
P304
P356
10.1111/J.1365-2265.2008.03221.X
P577
2008-02-13T00:00:00Z